on SHS Gesellschaft Für Beteiligungsmanagement MbH
SHS Capital Invests €10 Million in Develco to Boost Growth
SHS Capital, alongside its partners, is investing approximately €10 million in Develco Pharma. This investment aims to address strong market demand by expanding manufacturing capacities and advancing product development. Develco, based in the DACH region, specializes in innovative modified release drug formulations, primarily in pain management.
SHS Capital has supported Develco since 2020, enhancing its management team with industry experts. This strategic backing has enabled Develco to expand its product offerings and register its drugs in new markets, resulting in double-digit growth.
The current investment aligns with Develco's focus on increasing production capacity and operational efficiency to meet the growing demand. SHS Capital continues to provide high-quality investment opportunities to its limited partners.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SHS Gesellschaft Für Beteiligungsmanagement MbH news